
NecstGen
Netherlands Center for the Clinical Advancement of Cell & Gene Therapies.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
€2.0m | Early VC | ||
Total Funding | 000k |
Related Content
NecstGen is a pioneering biotechnology center and non-profit Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapies. The company operates in the healthcare and biotechnology markets, providing essential services to researchers and developers of advanced therapies. NecstGen offers development support and Good Manufacturing Practice (GMP) production, ensuring that innovative therapies can be translated from research to real-world health solutions for patients. Their services include cell therapy development, viral vector manufacturing, and flexible GMP cleanroom rental. NecstGen collaborates with academic institutions and industry partners to push the boundaries of what's possible in gene and cell therapy. The business model revolves around providing specialized development and manufacturing services, generating revenue through service contracts and facility rentals. Key clients include biotech companies, research institutions, and healthcare providers focused on advanced therapeutic solutions.
Keywords: biotechnology, CDMO, cell therapy, gene therapy, GMP production, viral vectors, cleanroom rental, healthcare, research support, advanced therapies.